Mills Ch3 Breast

83

CHAPTER 3:  Breast

41. Wellings SR, Jensen HM, Marcum RG. An atlas of subgross pathology of the human breast with special reference to pos- sible precancerous lesions. J Natl Cancer Inst 1975;55(2): 231–273. 42. Rosen PP. Multinucleated mammary stromal giant cells: a benign lesion that simulates invasive carcinoma. Cancer 1979; 44(4):1305–1308. 43. Russo J, Russo IH. Development of the human mammary gland. In: Neville MC, Daniel CW, eds. The Mammary Gland Development, Regulation and Function . New York: Plenum Press; 1987:67–93. 44. Russo J, Rivera R, Russo IH. Influence of age and parity on the development of the human breast. Breast Cancer Res Treat 1992;23(3):211–218. 45. Russo J, Romero AL, Russo IH. Architectural pattern of the normal and cancerous breast under the influence of parity. Cancer Epidemiol Biomarkers Prev 1994;3(3):219–224. 46. Baer HJ, Collins LC, Connolly JL, et al. Lobule type and sub- sequent breast cancer risk: Results from the Nurses’ Health Studies. Cancer 2009;115(7):1404–1411. 47. Milanese TR, Hartmann LC, Sellers TA, et al. Age-related lobular involution and risk of breast cancer. J Natl Cancer Inst 2006;98(22):1600–1607. 48. Radisky DC, Visscher DW, Frank RD, et al. Natural history of age-related lobular involution and impact on breast cancer risk. Breast Cancer Res Treat 2016;155(3):423–430. 49. Vierkant RA, Hartmann LC, Pankratz VS, et al. Lobular invo- lution: Localized phenomenon or field effect? Breast Cancer Res Treat 2009;117(1):193–196. 50. Vogel PM, Georgiade NG, Fetter BF, et al. The correlation of histologic changes in the human breast with the menstrual cycle. Am J Pathol 1981;104(1):23–34. 51. Longacre TA, Bartow SA. A correlative morphologic study of human breast and endometrium in the menstrual cycle. Am J Surg Pathol 1986;10(6):382–393. 52. Ramakrishnan R, Khan SA, Badve S. Morphological changes in breast tissue withmenstrual cycle. Mod Pathol 2002;15(12): 1348–1356. 53. Anderson TJ. Normal breast: myths, realities, and prospects. Mod Pathol 1998;11(2):115–119. 54. Tavassoli FA, Yeh IT. Lactational and clear cell changes of the breast in nonlactating, nonpregnant women. Am J Clin Pathol 1987;87(1):23–29. 55. Toker C. Clear cells of the nipple epidermis. Cancer 1970; 25(3):601–610. 56. Kohler S, Rouse RV, Smoller BR. The differential diagnosis of pagetoid cells in the epidermis. Mod Pathol 1998;11(1): 79–92. 57. Rosen PP, Tench W. Lobules in the nipple. Frequency and significance for breast cancer treatment. Pathol Annu 1985; 20(Pt 2):317–322. 58. Schnitt SJ, Goldwyn RM, Slavin SA. Mammary ducts in the areola: implications for patients undergoing reconstructive sur- gery of the breast. Plast Reconstr Surg 1993;92(7):1290–1293. 59. Smith DM, Jr., Peters TG, Donegan WL. Montgomery’s areo- lar tubercle. A light microscopic study. Arch Pathol Lab Med 1982;106(2):60–63. 60. Egan RL, McSweeney MB. Intramammary lymph nodes. Cancer 1983;51(10):1838–1842. 61. Jadusingh IH. Intramammary lymph nodes. J Clin Pathol 1992;45(11):1023–1026.

62. Svane G, Franzen S. Radiologic appearance of nonpalpa- ble intramammary lymph nodes. Acta Radiol 1993;34(6): 577–580. 63. Oberman HA. Breast lesions confused with carcinoma. In: McDivitt R, Oberman H, Ozello L, ed. The Breast . Baltimore, MD: Williams and Wilkins; 1984:1–3. 64. Battersby S, Anderson TJ. Proliferative and secretory activity in the pregnant and lactating human breast. Virchows Arch A Pathol Anat Histopathol 1988;413(3):189–196. 65. Battersby S, Anderson TJ. Histological changes in breast tis- sue that characterize recent pregnancy. Histopathology 1989; 15(4):415–419. 66. Hutson SW, Cowen PN, Bird CC. Morphometric studies of age related changes in normal human breast and their signifi- cance for evolution of mammary cancer. J Clin Pathol 1985; 38(3):281–287. 67. Cowan DF, Herbert TA. Involution of the breast in women aged 50–104 years: A histopathological study of 102 cases. Surg Pathol 1989;2(4):323–333. 68. Rosen PP. Rosen’s Breast Pathology . 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2001:381–404. 69. Shoker BS, Jarvis C, Sibson DR, et al. Oestrogen receptor expression in the normal and pre-cancerous breast. J Pathol 1999;188(3):237–244. 70. Shaw JA, Udokang K, Mosquera JM, et al. Oestrogen recep- tors alpha and beta differ in normal human breast and breast carcinomas. J Pathol 2002;198(4):450–457. 71. Shaaban AM, O’Neill PA, Davies MP, et al. Declining estro- gen receptor-beta expression defines malignant progression of human breast neoplasia. Am J Surg Pathol 2003;27(12): 1502–1512. 72. Speirs V, Walker RA. New perspectives into the biological and clinical relevance of oestrogen receptors in the human breast. J Pathol 2007;211(5):499–506. 73. Younes M, Honma N. Estrogen receptor β . Arch Pathol Lab Med 2011;135(1):63–66. 74. Haldosen LA, Zhao C, Dahlman-Wright K. Estrogen recep- tor beta in breast cancer. Mol Cell Endocrinol 2014;382(1): 665–672. 75. Krishnamurthy S, Sneige N. Molecular and biologic mark- ers of premalignant lesions of human breast. Adv Anat Pathol 2002;9(3):185–197. 76. Wang X, Stolla M, Ring BZ, et al. p53 alteration in morpho- logically normal/benign breast tissue in patients with triple- negative high-grade breast carcinomas: breast p53 signature? Hum Pathol 2016;55:196–201. 77. Wang X, El-Halaby AA, Zhang H, et al. P53 alteration in morphologically normal/benign breast luminal cells in BRCA carriers with or without history of breast cancer. Hum Pathol 2017;68:22–25. 78. Siziopikou KP, Prioleau JE, Harris JR, et al. bcl-2 expression in the spectrum of preinvasive breast lesions. Cancer 1996;77(3): 499–506. 79. Egan MJ, Newman J, Crocker J, et al. Immunohistochemi- cal localization of S100 protein in benign and malignant conditions of the breast. Arch Pathol Lab Med 1987;111(1): 28–31. 80. Earl HM, McIlhinney RA, Wilson P, et al. Immunohisto- chemical study of beta- and kappa-casein in the human breast and breast carcinomas, using monoclonal antibodies. Cancer Res 1989;49(21):6070–6076.